Zhaoke Ophthalmology’s Cyclosporine A (CsA) Ophthalmic Gel Passed the Onsite Regulatory and Clinical Trial Inspections by the NMPA, and the GMP Compliance Inspection by the Guangdong Medical Products Administration

兆科眼科荣获第五届粤港澳大湾区生物科技创新企业50强评选“领军企业”奖项

Zhaoke Ophthalmology Won the “Best Small and Mid-Cap Company” Award at the “Embracing 2023: the Seventh Golden Hong Kong Stocks Annual Awards Ceremony”

Zhaoke Ophthalmology Reaches Exclusive Distribution Agreement to Commercialize TONO-i in Greater China for Self-Measurement of Intraocular Pressure

Zhaoke Ophthalmology’s Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children